Sionna Therapeutics, Inc.(SION)
Biotechnology
Rare Disease / Orphan Drug
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-09 | Thompson Peter A. Director | Sale | -85,918 | -3.36%2,469,959 | $44.86 | $3,854,281 | View SEC filing | |
| 2026-07-09 | ORBIMED ADVISORS LLC Director | Sale | -85,918 | -3.36%2,469,959 | $44.86 | $3,854,281 | View SEC filing | |
| 2026-07-07 | Fitzpatrick Jennifer Chief Legal Officer | Sale | -10,250 | -10.93%83,545 | $43.60 | $446,862 | View SEC filing | |
| 2026-07-02 | Thompson Peter A. Director | Sale | -115,844 | -4.34%2,555,877 | $45.50 | $5,270,902 | View SEC filing | |
| 2026-07-02 | ORBIMED ADVISORS LLC Director | Sale | -115,844 | -4.34%2,555,877 | $45.50 | $5,270,902 | View SEC filing | |
| 2026-05-29 | Thompson Peter A. Director | Sale | -101 | -0.00%2,671,721 | $44.49 | $4,493 | View SEC filing | |
| 2026-05-29 | ORBIMED ADVISORS LLC Director | Sale | -101 | -0.00%2,671,721 | $44.49 | $4,493 | View SEC filing | |
| 2026-05-11 | Thompson Peter A. Director | Sale | -292,952 | -9.88%2,671,822 | $45.62 | $13,364,065 | View SEC filing | |
| 2026-05-11 | ORBIMED ADVISORS LLC Director | Sale | -292,952 | -9.88%2,671,822 | $45.62 | $13,364,065 | View SEC filing | |
| 2026-04-21 | Thompson Peter A. Director | Sale | -55,345 | -1.83%2,964,774 | $44.67 | $2,472,343 | View SEC filing | |
| 2026-04-21 | ORBIMED ADVISORS LLC Director | Sale | -55,345 | -1.83%2,964,774 | $44.67 | $2,472,343 | View SEC filing | |
| 2026-04-16 | Thompson Peter A. Director | Sale | -510,583 | -14.46%3,020,119 | $44.94 | $22,945,044 | View SEC filing | |
| 2026-04-16 | ORBIMED ADVISORS LLC Director | Sale | -510,583 | -14.46%3,020,119 | $44.94 | $22,945,044 | View SEC filing | |
| 2026-03-06 | Fitzpatrick Jennifer Chief Legal Officer | Sale | -10,250 | -100.00%0 | $33.86 | $347,019 | View SEC filing | |
| 2026-02-04 | Thompson Peter A. Director | Sale | -30,953 | -0.87%3,530,702 | $44.58 | $1,379,866 | View SEC filing | |
| 2026-02-04 | ORBIMED ADVISORS LLC Director | Sale | -30,953 | -0.87%3,530,702 | $44.58 | $1,379,866 | View SEC filing | |
| 2026-01-26 | COULTER JAMES G 10% Owner | Sale | -250,000 | -3.71%6,494,962 | $40.00 | $10,000,000 | View SEC filing | |
| 2025-12-29 | ORBIMED ADVISORS LLC Director | Sale | -33,356 | -0.93%3,561,655 | $44.55 | $1,486,010 | View SEC filing | |
| 2025-12-29 | Thompson Peter A. Director | Sale | -33,356 | -0.93%3,561,655 | $44.55 | $1,486,010 | View SEC filing | |
| 2025-12-19 | ORBIMED ADVISORS LLC Director | Sale | -1,875 | -0.05%3,595,011 | $44.49 | $83,428 | View SEC filing | |
| 2025-12-19 | Thompson Peter A. Director | Sale | -1,875 | -0.05%3,595,011 | $44.49 | $83,428 | View SEC filing | |
| 2025-12-09 | Fitzpatrick Jennifer Chief Legal Officer | Sale | -10,250 | -100.00%0 | $40.52 | $415,330 | View SEC filing | |
| 2025-11-26 | ORBIMED ADVISORS LLC Director | Sale | -108,073 | -2.92%3,596,886 | $44.55 | $4,814,205 | View SEC filing | |
| 2025-11-26 | Thompson Peter A. Director | Sale | -108,073 | -2.92%3,596,886 | $44.55 | $4,814,205 | View SEC filing | |
| 2025-11-24 | RA Capital Healthcare Fund LP Director, 10% Owner | Sale | -30,316 | -97.69%159,033 | $39.61 | $1,200,704 | View SEC filing |
1-25 of 48